Trial intelligence / Profile preview

Testogel in Male Hypogonadism

NCT01786473Phase 3Unknown

Sponsor
Besins Healthcare
Start
Dec 2012
Primary completion
Dec 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of AndroForte in male hypogonadism, sponsored by Besins Healthcare. Status: unknown.

02

Drugs

AndroForte
03

Conditions

male hypogonadism

Beyond the preview

Go deeper on NCT01786473.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01786473.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call